(Q43636277)

English

Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype

scientific article published in June 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

0 references

chronic heart failure

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

Cicoira M

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Zanolla L

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Rossi A

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Golia G

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Franceschini L

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Bonizzato A

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Graziani M

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Anker SD

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Coats AJ

10

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Zardini P

11

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

1 June 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1808-1812

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Captopril in heart failure. A double blind controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of heart failure: The Task Force of the Working Group on Heart Failure of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Does angiotensin-converting enzyme polymorphism influence the clinical manifestation and progression of heart failure in patients with dilated cardiomyopathy?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial). CONSENSUS Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Aldosterone escape during ACE inhibitor therapy in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901237-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(01)01237-2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43636277&oldid=2102021922"